Release Date: December 23, 2025
Expiration Date: December 23, 2026
Activity Overview
This educational activity is an archive of the live presentation held on Monday, December 8, 2025.
For more information about this educational activity, the faculty,
and disclosures, please click here.
Target Audience
This educational activity is primarily directed toward academic & community medical oncologists, APPs, oncology nurses, pharmacists, and other HCPs involved in the diagnosis and management of patients with breast cancer.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Discuss current and emerging frontline and maintenance options for the management of HER2+ mBC
- Develop tailored maintenance regimens for individual patients with HER2+ mBC to balance disease control with quality of life
- Manage adverse effects associated with frontline treatments for HER2+ mBC
Sara A. Hurvitz, MD, FACP
Professor of Medicine Head, Division of Hematology and Oncology
University of Washington Medicine
Senior Vice President, Clinical Research Division
Fred Hutchinson Cancer Center
Seattle, WA
Rena Callahan, MD
Associate Clinical Professor of Medicine
UCLA Hematology-Oncology
University of California, Los Angeles
Los Angeles, CA
Michelle Melisko, MD
Clinical Professor of Medicine
Department of Medicine
University of California, San Francisco
Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Paolo Tarantino, MD, PhD
Clinical Fellow Breast Oncology Center
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA
Full faculty information and disclosures are available by reviewing the program workbook, linked here.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all COI for faculty, staff, and planners prior to the start of this activity.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.